HEADER HYDROLASE 11-MAY-99 1QH7 TITLE CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLASES: A 2,5B TITLE 2 CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMIDIATE REVEALED BY THE TITLE 3 STRUCTURE OF THE BACILLUS AGARADHAERENS FAMILY 11 XYLANASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: XYLANASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FAMILY 11 XYLANASE CATALYTIC DOMAIN; COMPND 5 EC: 3.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: B-D-XYLANOPYRANOSIDE PRESENT IN THE ACTIVE SITE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS AGARADHAERENS; SOURCE 3 ORGANISM_TAXID: 76935; SOURCE 4 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 1423 KEYWDS GLYCOSYL HYDROLASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.SABINI,G.SULZENBACHER,M.DAUTER,Z.DAUTER,P.L.JORGENSEN,M.SCHULEIN, AUTHOR 2 C.DUPONT,G.J.DAVIES,K.S.WILSON REVDAT 6 13-NOV-24 1QH7 1 REMARK REVDAT 5 27-DEC-23 1QH7 1 HETSYN REVDAT 4 29-JUL-20 1QH7 1 COMPND REMARK HETNAM SITE REVDAT 4 2 1 ATOM REVDAT 3 25-DEC-19 1QH7 1 SEQADV SEQRES LINK REVDAT 2 24-FEB-09 1QH7 1 VERSN REVDAT 1 17-MAY-00 1QH7 0 JRNL AUTH E.SABINI,G.SULZENBACHER,M.DAUTER,Z.DAUTER,P.L.JORGENSEN, JRNL AUTH 2 M.SCHULEIN,C.DUPONT,G.J.DAVIES,K.S.WILSON JRNL TITL CATALYSIS AND SPECIFICITY IN ENZYMATIC GLYCOSIDE HYDROLYSIS: JRNL TITL 2 A 2,5B CONFORMATION FOR THE GLYCOSYL-ENZYME INTERMEDIATE JRNL TITL 3 REVEALED BY THE STRUCTURE OF THE BACILLUS AGARADHAERENS JRNL TITL 4 FAMILY 11 XYLANASE. JRNL REF CHEM.BIOL. V. 6 483 1999 JRNL REFN ISSN 1074-5521 JRNL PMID 10381409 JRNL DOI 10.1016/S1074-5521(99)80066-0 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 41488 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.117 REMARK 3 FREE R VALUE : 0.176 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1285 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3270 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 611 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.013 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.031 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.031 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.014 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.120 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.170 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.249 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : 0.107 ; 0.300 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 5.500 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 13.600; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 27.200; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.182 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.877 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.822 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.785 ; 3.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1QH7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000001038. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40782 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 54.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : 5.50000 REMARK 200 FOR THE DATA SET : 27.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.16200 REMARK 200 R SYM FOR SHELL (I) : 16.2000 REMARK 200 FOR SHELL : 6.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULPHATE 30%, MES 0.1M PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.93000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.68000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.93000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.68000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PCA A 1 O - C - N ANGL. DEV. = -15.2 DEGREES REMARK 500 TYR A 16 CB - CG - CD2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 49 CG - CD - NE ANGL. DEV. = 12.9 DEGREES REMARK 500 ARG A 49 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 105 NE - CZ - NH2 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 129 NE - CZ - NH1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG A 148 NE - CZ - NH1 ANGL. DEV. = 8.0 DEGREES REMARK 500 ARG A 148 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG A 164 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 200 CD - NE - CZ ANGL. DEV. = 9.4 DEGREES REMARK 500 ARG A 200 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 200 NE - CZ - NH2 ANGL. DEV. = -6.7 DEGREES REMARK 500 PCA B 1 O - C - N ANGL. DEV. = -14.0 DEGREES REMARK 500 ARG B 49 CG - CD - NE ANGL. DEV. = 13.9 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 13.4 DEGREES REMARK 500 ARG B 148 NE - CZ - NH2 ANGL. DEV. = -7.4 DEGREES REMARK 500 ARG B 152 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG B 164 CD - NE - CZ ANGL. DEV. = 8.9 DEGREES REMARK 500 ARG B 200 NE - CZ - NH1 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG B 200 NE - CZ - NH2 ANGL. DEV. = -7.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 197 95.25 -166.01 REMARK 500 ASN B 77 75.68 -119.93 REMARK 500 ASN B 197 103.15 -164.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: NUA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC NUCLEOPHILE REMARK 800 REMARK 800 SITE_IDENTIFIER: NUB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC NUCLEOPHILE REMARK 800 REMARK 800 SITE_IDENTIFIER: ACA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC ACID / BASE REMARK 800 REMARK 800 SITE_IDENTIFIER: ACB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC ACID / BASE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QH6 RELATED DB: PDB DBREF 1QH7 A 2 207 UNP Q7SIE3 Q7SIE3_BACAG 2 207 DBREF 1QH7 B 2 207 UNP Q7SIE3 Q7SIE3_BACAG 2 207 SEQRES 1 A 207 PCA ILE VAL THR ASP ASN SER ILE GLY ASN HIS ASP GLY SEQRES 2 A 207 TYR ASP TYR GLU PHE TRP LYS ASP SER GLY GLY SER GLY SEQRES 3 A 207 THR MET ILE LEU ASN HIS GLY GLY THR PHE SER ALA GLN SEQRES 4 A 207 TRP ASN ASN VAL ASN ASN ILE LEU PHE ARG LYS GLY LYS SEQRES 5 A 207 LYS PHE ASN GLU THR GLN THR HIS GLN GLN VAL GLY ASN SEQRES 6 A 207 MET SER ILE ASN TYR GLY ALA ASN PHE GLN PRO ASN GLY SEQRES 7 A 207 ASN ALA TYR LEU CYS VAL TYR GLY TRP THR VAL ASP PRO SEQRES 8 A 207 LEU VAL GLU TYR TYR ILE VAL ASP SER TRP GLY ASN TRP SEQRES 9 A 207 ARG PRO PRO GLY ALA THR PRO LYS GLY THR ILE THR VAL SEQRES 10 A 207 ASP GLY GLY THR TYR ASP ILE TYR GLU THR LEU ARG VAL SEQRES 11 A 207 ASN GLN PRO SER ILE LYS GLY ILE ALA THR PHE LYS GLN SEQRES 12 A 207 TYR TRP SER VAL ARG ARG SER LYS ARG THR SER GLY THR SEQRES 13 A 207 ILE SER VAL SER ASN HIS PHE ARG ALA TRP GLU ASN LEU SEQRES 14 A 207 GLY MET ASN MET GLY LYS MET TYR GLU VAL ALA LEU THR SEQRES 15 A 207 VAL GLU GLY TYR GLN SER SER GLY SER ALA ASN VAL TYR SEQRES 16 A 207 SER ASN THR LEU ARG ILE ASN GLY ASN PRO LEU SER SEQRES 1 B 207 PCA ILE VAL THR ASP ASN SER ILE GLY ASN HIS ASP GLY SEQRES 2 B 207 TYR ASP TYR GLU PHE TRP LYS ASP SER GLY GLY SER GLY SEQRES 3 B 207 THR MET ILE LEU ASN HIS GLY GLY THR PHE SER ALA GLN SEQRES 4 B 207 TRP ASN ASN VAL ASN ASN ILE LEU PHE ARG LYS GLY LYS SEQRES 5 B 207 LYS PHE ASN GLU THR GLN THR HIS GLN GLN VAL GLY ASN SEQRES 6 B 207 MET SER ILE ASN TYR GLY ALA ASN PHE GLN PRO ASN GLY SEQRES 7 B 207 ASN ALA TYR LEU CYS VAL TYR GLY TRP THR VAL ASP PRO SEQRES 8 B 207 LEU VAL GLU TYR TYR ILE VAL ASP SER TRP GLY ASN TRP SEQRES 9 B 207 ARG PRO PRO GLY ALA THR PRO LYS GLY THR ILE THR VAL SEQRES 10 B 207 ASP GLY GLY THR TYR ASP ILE TYR GLU THR LEU ARG VAL SEQRES 11 B 207 ASN GLN PRO SER ILE LYS GLY ILE ALA THR PHE LYS GLN SEQRES 12 B 207 TYR TRP SER VAL ARG ARG SER LYS ARG THR SER GLY THR SEQRES 13 B 207 ILE SER VAL SER ASN HIS PHE ARG ALA TRP GLU ASN LEU SEQRES 14 B 207 GLY MET ASN MET GLY LYS MET TYR GLU VAL ALA LEU THR SEQRES 15 B 207 VAL GLU GLY TYR GLN SER SER GLY SER ALA ASN VAL TYR SEQRES 16 B 207 SER ASN THR LEU ARG ILE ASN GLY ASN PRO LEU SER MODRES 1QH7 PCA A 1 GLN PYROGLUTAMIC ACID MODRES 1QH7 PCA B 1 GLN PYROGLUTAMIC ACID HET PCA A 1 8 HET PCA B 1 8 HET XYP A1001 10 HET XYP B1002 10 HETNAM PCA PYROGLUTAMIC ACID HETNAM XYP BETA-D-XYLOPYRANOSE HETSYN XYP BETA-D-XYLOSE; D-XYLOSE; XYLOSE FORMUL 1 PCA 2(C5 H7 N O3) FORMUL 3 XYP 2(C5 H10 O5) FORMUL 5 HOH *611(H2 O) HELIX 1 1 HIS A 60 VAL A 63 1 4 HELIX 2 2 VAL A 159 LEU A 169 1 11 HELIX 3 3 HIS B 60 VAL B 63 1 4 HELIX 4 4 VAL B 159 ASN B 168 1 10 SHEET 1 A 9 SER A 7 HIS A 11 0 SHEET 2 A 9 TYR A 14 LYS A 20 -1 N PHE A 18 O SER A 7 SHEET 3 A 9 ASN A 45 LYS A 53 -1 N GLY A 51 O ASP A 15 SHEET 4 A 9 LYS A 175 TYR A 186 -1 N GLY A 185 O ILE A 46 SHEET 5 A 9 ASN A 79 VAL A 89 -1 N VAL A 89 O LYS A 175 SHEET 6 A 9 VAL A 93 TRP A 101 -1 N SER A 100 O LEU A 82 SHEET 7 A 9 PHE A 141 ARG A 148 1 N LYS A 142 O GLU A 94 SHEET 8 A 9 GLY A 120 ARG A 129 -1 N ARG A 129 O PHE A 141 SHEET 9 A 9 GLY A 113 VAL A 117 -1 N VAL A 117 O GLY A 120 SHEET 1 B 5 SER A 25 LEU A 30 0 SHEET 2 B 5 PHE A 36 ASN A 41 -1 N ASN A 41 O SER A 25 SHEET 3 B 5 SER A 189 ILE A 201 -1 N VAL A 194 O PHE A 36 SHEET 4 B 5 MET A 66 ASN A 77 -1 N ASN A 77 O SER A 189 SHEET 5 B 5 SER A 154 SER A 158 -1 N ILE A 157 O ILE A 68 SHEET 1 C 9 SER B 7 HIS B 11 0 SHEET 2 C 9 TYR B 14 LYS B 20 -1 N PHE B 18 O SER B 7 SHEET 3 C 9 ASN B 45 LYS B 53 -1 N GLY B 51 O ASP B 15 SHEET 4 C 9 LYS B 175 TYR B 186 -1 N GLY B 185 O ILE B 46 SHEET 5 C 9 ALA B 80 VAL B 89 -1 N VAL B 89 O LYS B 175 SHEET 6 C 9 VAL B 93 TRP B 101 -1 N SER B 100 O LEU B 82 SHEET 7 C 9 PHE B 141 ARG B 148 1 N LYS B 142 O GLU B 94 SHEET 8 C 9 GLY B 120 ARG B 129 -1 N ARG B 129 O PHE B 141 SHEET 9 C 9 GLY B 113 VAL B 117 -1 N VAL B 117 O GLY B 120 SHEET 1 D 5 SER B 25 LEU B 30 0 SHEET 2 D 5 PHE B 36 ASN B 41 -1 N ASN B 41 O SER B 25 SHEET 3 D 5 SER B 189 ILE B 201 -1 N VAL B 194 O PHE B 36 SHEET 4 D 5 MET B 66 ASN B 77 -1 N ASN B 77 O SER B 189 SHEET 5 D 5 SER B 154 ILE B 157 -1 N ILE B 157 O ILE B 68 SHEET 1 E 2 GLN B 132 SER B 134 0 SHEET 2 E 2 GLY B 137 ALA B 139 -1 N ALA B 139 O GLN B 132 LINK C PCA A 1 N ILE A 2 1555 1555 1.41 LINK C PCA B 1 N ILE B 2 1555 1555 1.39 CISPEP 1 ASP A 90 PRO A 91 0 2.12 CISPEP 2 PRO A 106 PRO A 107 0 1.02 CISPEP 3 ASP B 90 PRO B 91 0 6.93 CISPEP 4 PRO B 106 PRO B 107 0 2.23 SITE 1 NUA 1 GLU A 94 SITE 1 NUB 1 GLU B 94 SITE 1 ACA 1 GLU A 184 SITE 1 ACB 1 GLU B 184 CRYST1 71.860 75.360 78.400 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013916 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013270 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012755 0.00000 MTRIX1 1 0.959850 -0.280398 -0.008088 33.80553 1 MTRIX2 1 0.279233 0.957821 -0.067883 43.97223 1 MTRIX3 1 0.026781 0.062899 0.997661 -0.97119 1 HETATM 1 N PCA A 1 12.687 12.631 31.386 1.00 15.52 N ANISOU 1 N PCA A 1 2216 2235 1445 53 -221 -96 N HETATM 2 CA PCA A 1 12.154 12.511 30.051 1.00 15.70 C ANISOU 2 CA PCA A 1 2028 2448 1490 185 -176 -103 C HETATM 3 CB PCA A 1 12.783 11.269 29.408 1.00 16.40 C ANISOU 3 CB PCA A 1 2530 2332 1369 343 -260 -138 C HETATM 4 CG PCA A 1 13.122 10.414 30.666 1.00 17.35 C ANISOU 4 CG PCA A 1 2722 2548 1321 259 -172 -122 C HETATM 5 CD PCA A 1 13.319 11.482 31.757 1.00 16.52 C ANISOU 5 CD PCA A 1 2369 2425 1485 231 -300 -106 C HETATM 6 OE PCA A 1 13.999 11.282 32.812 1.00 15.03 O ANISOU 6 OE PCA A 1 2230 2332 1147 433 -151 -201 O HETATM 7 C PCA A 1 10.635 12.319 30.020 1.00 14.41 C ANISOU 7 C PCA A 1 2028 2222 1226 22 -23 -53 C HETATM 8 O PCA A 1 9.835 11.991 29.118 1.00 12.79 O ANISOU 8 O PCA A 1 1526 2099 1234 44 48 -16 O